CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in CELC — Celcuity Inc.
CIK 884546
SAN FRANCISCO, CA
Position in CELC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$33,544,832
+$4,389,334 QoQ
Shares Held
293,892
+0.5% QoQ
Ownership
0.603%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,181,979,796 across 287 Biotechnology names. CELC ranks #42 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in CELC
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,544,832 | 293,892 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $29,155,498 | 292,315 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $13,276,200 | 268,749 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,111,337 | 233,059 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,345,883 | 232,036 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $3,111,571 | 237,706 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,305,114 | 221,671 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,113,168 | 67,959 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $978,760 | 45,313 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $659,685 | 45,277 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $430,960 | 47,151 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $486,677 | 44,324 | Shares | Sole | 2023-08-10 | |
| 2022-03-31 | $255,030 | 27,276 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $333,535 | 25,287 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $455,166 | 25,287 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $465,720 | 19,405 | Shares | Sole | 2021-08-16 | |
| 2020-03-31 | $95,608 | 14,709 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||